XLRS Gene Therapy

About TeamedOn

TeamedOn is a private, pre-clinical stage biotech founded in 2020 and headquartered in Rockville, MD, USA, focusing on gene therapies for rare ophthalmic diseases. Its lead program targets X-linked Retinoschisis (XLRS), an orphan disease with no effective treatment, utilizing a viral vector-based gene replacement strategy. The company is led by a small team with extensive industry experience in drug development and is supported by key clinical advisors from leading ophthalmology institutions. TeamedOn operates as a pre-revenue therapeutics developer seeking partnerships to advance its pipeline.

Therapeutic Areas